Innate immune responsive inflammation in development of progressive myopia.

Suqi PanJianshu YuanYuanhui JinXiaotian LiuShanjun WuYuwen WangHongyan YaoLingyun Cheng

Published in: Eye (London, England) (2024)

sICAM-1 and MCP-1 in ocular fluid may be indicative biomarkers for progressive high myopia and the underneath autoimmune inflammation. sICAM-1 may be used as a monitoring biomarker for development of pathologic myopia.

Keyphrases

multiple sclerosis
innate immune
oxidative stress
optic nerve
neoadjuvant chemotherapy
squamous cell carcinoma
cancer therapy
lymph node
locally advanced
drug induced